BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blair VR, McLeod M, Carneiro F, Coit DG, D'Addario JL, van Dieren JM, Harris KL, Hoogerbrugge N, Oliveira C, van der Post RS, Arnold J, Benusiglio PR, Bisseling TM, Boussioutas A, Cats A, Charlton A, Schreiber KEC, Davis JL, Pietro MD, Fitzgerald RC, Ford JM, Gamet K, Gullo I, Hardwick RH, Huntsman DG, Kaurah P, Kupfer SS, Latchford A, Mansfield PF, Nakajima T, Parry S, Rossaak J, Sugimura H, Svrcek M, Tischkowitz M, Ushijima T, Yamada H, Yang HK, Claydon A, Figueiredo J, Paringatai K, Seruca R, Bougen-Zhukov N, Brew T, Busija S, Carneiro P, DeGregorio L, Fisher H, Gardner E, Godwin TD, Holm KN, Humar B, Lintott CJ, Monroe EC, Muller MD, Norero E, Nouri Y, Paredes J, Sanches JM, Schulpen E, Ribeiro AS, Sporle A, Whitworth J, Zhang L, Reeve AE, Guilford P. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol 2020;21:e386-97. [PMID: 32758476 DOI: 10.1016/S1470-2045(20)30219-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 20.5] [Reference Citation Analysis]
Number Citing Articles
1 Coit DG, Strong VE. Fifty years of progress in gastric cancer. J Surg Oncol 2022;126:865-71. [PMID: 36087088 DOI: 10.1002/jso.27060] [Reference Citation Analysis]
2 Bücker L, Lehmann U. CDH1 (E-cadherin) Gene Methylation in Human Breast Cancer: Critical Appraisal of a Long and Twisted Story. Cancers 2022;14:4377. [DOI: 10.3390/cancers14184377] [Reference Citation Analysis]
3 Leite ACR, Suzuki DA, Pereira AAL, Machado NP, Barroso-sousa R, Correa TS, Moura FC, Morbeck IAP, Gumz BP, Faria LDBB, Fernandes GDS, Sandoval RL. What can we learn from more than 1,000 Brazilian patients at risk of hereditary cancer? Front Oncol 2022;12:963910. [DOI: 10.3389/fonc.2022.963910] [Reference Citation Analysis]
4 Stillman MD, Kusche N, Toledano S, Hilfrank KJ, Yoon C, Gabre JT, Rustgi SD, Hur C, Kastrinos F, Ryeom SW, Yoon SS. Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene. J Surg Oncol 2022. [PMID: 36063148 DOI: 10.1002/jso.27084] [Reference Citation Analysis]
5 Shah IH, Salo-Mullen EE, Amoroso KA, Kelsen D, Stadler ZK, Hamilton JG. Attitudes toward preimplantation genetic testing and quality of life among individuals with hereditary diffuse gastric cancer syndrome. Hered Cancer Clin Pract 2022;20:31. [PMID: 36056367 DOI: 10.1186/s13053-022-00239-9] [Reference Citation Analysis]
6 Coudert M, Drouet Y, Delhomelle H, Svrcek M, Benusiglio PR, Coulet F, Clark DF, Katona BW, van Hest LP, van der Kolk LE, Cats A, van Dieren JM, Nehoray B, Slavin T, Spier I, Hüneburg R, Lobo S, Oliveira C, Boussemart L, Masson L, Chiesa J, Schwartz M, Buecher B, Golmard L, Bouvier AM, Bonadona V, Stoppa-Lyonnet D, Lasset C, Colas C. First estimates of diffuse gastric cancer risks for carriers of CTNNA1 germline pathogenic variants. J Med Genet 2022:jmedgenet-2022-108740. [PMID: 36038258 DOI: 10.1136/jmg-2022-108740] [Reference Citation Analysis]
7 Yurgelun MB, Uno H, Furniss CS, Ukaegbu C, Horiguchi M, Yussuf A, LaDuca H, Chittenden A, Garber JE, Syngal S. Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment. J Clin Oncol 2022;:JCO2200120. [PMID: 35960913 DOI: 10.1200/JCO.22.00120] [Reference Citation Analysis]
8 Tutty E, Forbes Shepherd R, Hoskins C, Purvis R, Shanahan M, Boussioutas A, Forrest LE. Becoming and being a parent with an inherited predisposition to diffuse gastric cancer: A qualitative study of young adults with a CDH1 pathogenic variant. J Psychosoc Oncol 2022;:1-17. [PMID: 35959852 DOI: 10.1080/07347332.2022.2104676] [Reference Citation Analysis]
9 Kabbage M, Ben Aissa-haj J, Othman H, Jaballah-gabteni A, Laarayedh S, Elouej S, Medhioub M, Kettiti HT, Khsiba A, Mahmoudi M, Belfekih H, Maaloul A, Touinsi H, Hamzaoui L, Chelbi E, Abdelhak S, Boubaker MS, Azzouz MM. A Rare MSH2 Variant as a Candidate Marker for Lynch Syndrome II Screening in Tunisia: A Case of Diffuse Gastric Carcinoma. Genes 2022;13:1355. [DOI: 10.3390/genes13081355] [Reference Citation Analysis]
10 Corso G, Tagliaferri V, Massari G, Cioffi A, Rossi EMC, Veronesi P, Magnoni F. CDH1 mutations recurrence and global clustering in genetically tested families with hereditary diffuse gastric cancer syndrome: results from a systematic study. Fam Cancer 2022. [PMID: 35882702 DOI: 10.1007/s10689-022-00309-w] [Reference Citation Analysis]
11 Teke ME, Gamble LA, Samaranayake SG, Green BL, Saif A, Hernandez JM, Davis JL. Soluble E-Cadherin as a Potential Biomarker in Hereditary Diffuse Gastric Cancer Syndrome. Ann Surg Oncol 2022. [PMID: 35882695 DOI: 10.1245/s10434-022-12288-4] [Reference Citation Analysis]
12 Ko YK, Gim J. New Drug Development and Clinical Trial Design by Applying Genomic Information Management. Pharmaceutics 2022;14:1539. [DOI: 10.3390/pharmaceutics14081539] [Reference Citation Analysis]
13 Schölzchen J, Treese C, Thuss-patience P, Mrózek A, Rau B, Seeliger H, Hartmann D, Estevéz-schwarz L, Siegmund B, Horn D, Nassir M, Daum S. Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian Cohort. Cancers 2022;14:3590. [DOI: 10.3390/cancers14153590] [Reference Citation Analysis]
14 Zhu Y, Sun T, Zhang L, Fei F, Bao Y, Gao Z, Solimando AG. Delineating Molecular Subtypes through Gene Set Variation Analysis Confers Therapeutic and Prognostic Capability in Gastric Cancer. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-11. [DOI: 10.1155/2022/5415758] [Reference Citation Analysis]
15 Cosma LS, Schlosser S, Tews HC, Müller M, Kandulski A. Hereditary Diffuse Gastric Cancer: Molecular Genetics, Biological Mechanisms and Current Therapeutic Approaches. Int J Mol Sci 2022;23:7821. [PMID: 35887173 DOI: 10.3390/ijms23147821] [Reference Citation Analysis]
16 Xue S, Zheng T, Yan J, Ma J, Lin C, Dong S, Wei C, Li T, Zhang X, Li G. Identification of a 3-Gene Model as Prognostic Biomarker in Patients With Gastric Cancer. Front Oncol 2022;12:930586. [DOI: 10.3389/fonc.2022.930586] [Reference Citation Analysis]
17 Roberts G, Benusiglio PR, Bisseling T, Coit D, Davis JL, Grimes S, Guise TA, Hardwick R, Harris K, Mansfield PF, Rossaak J, Schreiber KC, Stanich PP, Strong VE, Kaurah P; LAP-TG Study Group. International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) study. Gastric Cancer 2022. [PMID: 35831514 DOI: 10.1007/s10120-022-01318-5] [Reference Citation Analysis]
18 Gamble LA, Grant RRC, Samaranayake SG, Fasaye GA, Koh C, Korman L, Asif B, Heller T, Hernandez JM, Blakely AM, Davis JL. Decision-making and regret in patients with germline CDH1 variants undergoing prophylactic total gastrectomy. J Med Genet 2022:jmedgenet-2022-108733. [PMID: 35817563 DOI: 10.1136/jmg-2022-108733] [Reference Citation Analysis]
19 Zavros Y, Merchant JL. The immune microenvironment in gastric adenocarcinoma. Nat Rev Gastroenterol Hepatol 2022;19:451-67. [PMID: 35288702 DOI: 10.1038/s41575-022-00591-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, Vogel A, Smyth E. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology 2022. [DOI: 10.1016/j.annonc.2022.07.004] [Reference Citation Analysis]
21 Cerrato-Izaguirre D, Chirino YI, García-Cuellar CM, Santibáñez-Andrade M, Prada D, Hernández-Guerrero A, Larraga OA, Camacho J, Sánchez-Pérez Y. Mutational landscape of gastric adenocarcinoma in Latin America: A genetic approach for precision medicine. Genes Dis 2022;9:928-40. [PMID: 35685475 DOI: 10.1016/j.gendis.2021.04.002] [Reference Citation Analysis]
22 Carnevali I, Tedaldi G, Pensotti V, Sahnane N, Micello D, Rovera F, Sessa F, Tibiletti MG. Case Report: Male Lobular Breast Cancer in Hereditary Cancer Syndromes. Front Oncol 2022;12:891426. [PMID: 35686104 DOI: 10.3389/fonc.2022.891426] [Reference Citation Analysis]
23 Xu JL, Yuan L, Hu C, Weng CY, Xu HD, Shi YF, Huang L, Ying JE, Xu ZY, Qin JJ, Cheng XD. Trametes robiniophila Murr Sensitizes Gastric Cancer Cells to 5-Fluorouracil by Modulating Tumor Microenvironment. Front Pharmacol 2022;13:911663. [PMID: 35656301 DOI: 10.3389/fphar.2022.911663] [Reference Citation Analysis]
24 Corso G, Robson ME, Sacchini V. Points to Consider Regarding Risk-Reducing Mastectomy in High-, Moderate-, and Low-Penetrance Gene Carriers. Ann Surg Oncol 2022. [PMID: 35604619 DOI: 10.1245/s10434-022-11913-6] [Reference Citation Analysis]
25 Carneiro F. Familial and hereditary gastric cancer, an overview. Best Practice & Research Clinical Gastroenterology 2022. [DOI: 10.1016/j.bpg.2022.101800] [Reference Citation Analysis]
26 Shah D, Bentrem D. Environmental and genetic risk factors for gastric cancer. J Surg Oncol 2022;125:1096-103. [PMID: 35481919 DOI: 10.1002/jso.26869] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Kostov S, Watrowski R, Kornovski Y, Dzhenkov D, Slavchev S, Ivanova Y, Yordanov A. Hereditary Gynecologic Cancer Syndromes - A Narrative Review. Onco Targets Ther 2022;15:381-405. [PMID: 35422633 DOI: 10.2147/OTT.S353054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Leaf RK, Dhami RS, Chun NS, Ta R. Case 11-2022: An 80-Year-Old Woman with Pancytopenia. N Engl J Med 2022;386:1453-61. [PMID: 35417641 DOI: 10.1056/NEJMcpc2201232] [Reference Citation Analysis]
29 Treese C, Siegmund B, Daum S. Hereditary Diffuse Gastric Cancer—Update Based on the Current Consort Recommendations. Current Oncology 2022;29:2454-60. [DOI: 10.3390/curroncol29040199] [Reference Citation Analysis]
30 Bougen-Zhukov N, Decourtye-Espiard L, Mitchell W, Redpath K, Perkinson J, Godwin T, Black MA, Guilford P. E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib. Cancers (Basel) 2022;14:1609. [PMID: 35406381 DOI: 10.3390/cancers14071609] [Reference Citation Analysis]
31 Abnet CC. Asian Gastric Cardia Adenocarcinoma: A distinct and understudied cancer with etiologic similarities to both esophageal squamous cell carcinoma and noncardia gastric adenocarcinoma. J Natl Cancer Cent 2021;1:44-6. [PMID: 35291693 DOI: 10.1016/j.jncc.2021.03.001] [Reference Citation Analysis]
32 Monster JL, Kemp LJS, Gloerich M, van der Post RS. Diffuse gastric cancer: Emerging mechanisms of tumor initiation and progression. Biochim Biophys Acta Rev Cancer 2022;:188719. [PMID: 35307354 DOI: 10.1016/j.bbcan.2022.188719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Corso G. Pleiotropic cancer manifestations of germline CDH1 mutations: Risks and management. Journal of Surgical Oncology. [DOI: 10.1002/jso.26847] [Reference Citation Analysis]
34 Corso G, Magnoni F, Nicastro V, Bagnardi V, Trovato CM, Veronesi P. Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations. Seminars in Oncology 2022. [DOI: 10.1053/j.seminoncol.2022.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Sommer AK, te Paske IB, Garcia-pelaez J, Laner A, Holinski-feder E, Steinke-lange V, Peters S, Valle L, Spier I, Huntsman D, Capella G, Evans G, Rump A, Schröck E, Hoischen A, Geverink N, Tischkowitz M, Matalonga L, Laurie S, Gilissen C, Steyaert W, Demidov G, Oliveira C, de Voer RM, Hoogerbrugge N, Aretz S. Solving the genetic aetiology of hereditary gastrointestinal tumour syndromes– a collaborative multicentre endeavour within the project Solve-RD. European Journal of Medical Genetics 2022. [DOI: 10.1016/j.ejmg.2022.104475] [Reference Citation Analysis]
36 Forrester JD, Foster D, Ford JM, Longacre TA, Ladabaum U, Fry S, Norton JA. Surgery for Hereditary Diffuse Gastric Cancer: Long-Term Outcomes. Cancers (Basel) 2022;14:728. [PMID: 35158993 DOI: 10.3390/cancers14030728] [Reference Citation Analysis]
37 Lerner BA, Xicola RM, Rodriguez NJ, Karam R, Llor X. Simplified and more sensitive criteria for identifying individuals with pathogenic CDH1 variants. J Med Genet. [DOI: 10.1136/jmedgenet-2021-108169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Yi C, Zhang X, Chen X, Huang B, Song J, Ma M, Yuan X, Zhang C. A novel 8-genome instability-associated lncRNAs signature predicting prognosis and drug sensitivity in gastric cancer. Int J Immunopathol Pharmacol 2022;36:3946320221103195. [PMID: 35696730 DOI: 10.1177/03946320221103195] [Reference Citation Analysis]
39 Benusiglio PR, Fallet V, Sanchis-Borja M, Coulet F, Cadranel J. Lung cancer is also a hereditary disease. Eur Respir Rev 2021;30:210045. [PMID: 34670806 DOI: 10.1183/16000617.0045-2021] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
40 Decourtye-Espiard L, Bougen-Zhukov N, Godwin T, Brew T, Schulpen E, Black MA, Guilford P. E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors. Cancers (Basel) 2021;14:175. [PMID: 35008338 DOI: 10.3390/cancers14010175] [Reference Citation Analysis]
41 Brew T, Bougen-Zhukov N, Mitchell W, Decourtye L, Schulpen E, Nouri Y, Godwin T, Guilford P. Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle Trafficking. Cancers (Basel) 2021;14:102. [PMID: 35008266 DOI: 10.3390/cancers14010102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Corso G, Magnoni F, Massari G, Trovato CM, De Scalzi AM, Vicini E, Bonanni B, Veronesi P, Galimberti V, Bagnardi V. CDH1 germline mutations in healthy individuals from families with the hereditary diffuse gastric cancer syndrome. J Med Genet 2021:jmedgenet-2021-108226. [PMID: 34952833 DOI: 10.1136/jmedgenet-2021-108226] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Adib E, El Zarif T, Nassar AH, Akl EW, Abou Alaiwi S, Mouhieddine TH, Esplin ED, Hatchell K, Nielsen SM, Rana HQ, Choueiri TK, Kwiatkowski DJ, Sonpavde G. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer. Br J Cancer 2021. [PMID: 34949788 DOI: 10.1038/s41416-021-01673-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Pereira F, Teixeira MR, Dinis Ribeiro M, Brandão C. Multi-Gene Panel Testing in Gastroenterology: Are We Ready for the Results? GE Port J Gastroenterol 2021;28:403-9. [PMID: 34901447 DOI: 10.1159/000513966] [Reference Citation Analysis]
45 Garcia-Pelaez J, Barbosa-Matos R, São José C, Sousa S, Gullo I, Hoogerbrugge N, Carneiro F, Oliveira C. Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes. Eur J Med Genet 2022;65:104401. [PMID: 34871783 DOI: 10.1016/j.ejmg.2021.104401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Gamble LA, Davis JL. Surveillance and Surgical Considerations in Hereditary Diffuse Gastric Cancer. Gastrointest Endosc Clin N Am 2022;32:163-75. [PMID: 34798984 DOI: 10.1016/j.giec.2021.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 McVeigh UM, Tepper JW, McVeigh TP. A Review of Breast Cancer Risk Factors in Adolescents and Young Adults. Cancers (Basel) 2021;13:5552. [PMID: 34771713 DOI: 10.3390/cancers13215552] [Reference Citation Analysis]
48 Wang Q, Xu C, Fan Q, Yuan H, Zhang X, Chen B, Cai R, Zhang Y, Lin M, Xu M. Positive feedback between ROS and cis-axis of PIASxα/p38α-SUMOylation/MK2 facilitates gastric cancer metastasis. Cell Death Dis 2021;12:986. [PMID: 34686655 DOI: 10.1038/s41419-021-04302-6] [Reference Citation Analysis]
49 Gamble LA, Rossi A, Fasaye GA, Kesserwan C, Hernandez JM, Blakely AM, Davis JL. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk. JAMA Surg 2021. [PMID: 34643667 DOI: 10.1001/jamasurg.2021.5118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
50 Figueiredo J, Ferreira RM, Xu H, Gonçalves M, Barros-Carvalho A, Cravo J, Maia AF, Carneiro P, Figueiredo C, Smith ML, Stamenović D, Morais-de-Sá E, Seruca R. Integrin β1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells. Gastric Cancer 2021. [PMID: 34486077 DOI: 10.1007/s10120-021-01239-9] [Reference Citation Analysis]
51 Barbosa-Matos R, Leal Silva R, Garrido L, Aguiar AC, Garcia-Pelaez J, André A, Seixas S, Sousa SP, Ferro L, Vilarinho L, Gullo I, Devezas V, Oliveira R, Fernandes S, Costa SC, Magalhães A, Baptista M, Carneiro F, Pinheiro H, Castedo S, Oliveira C. The CDH1 c.1901C>T Variant: A Founder Variant in the Portuguese Population with Severe Impact in mRNA Splicing. Cancers (Basel) 2021;13:4464. [PMID: 34503274 DOI: 10.3390/cancers13174464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
52 Figueiredo J, Mercadillo F, Melo S, Barroso A, Gonçalves M, Díaz-Tasende J, Carneiro P, Robles L, Colina F, Ibarrola C, Perea J, Morais-de-Sá E, Seruca R, Urioste M. Germline CDH1 G212E Missense Variant: Combining Clinical, In Vitro and In Vivo Strategies to Unravel Disease Burden. Cancers (Basel) 2021;13:4359. [PMID: 34503169 DOI: 10.3390/cancers13174359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
53 Gullo I, Grillo F, Mastracci L, Vanoli A, Carneiro F, Saragoni L, Limarzi F, Ferro J, Parente P, Fassan M. Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes. Pathologica 2020;112:166-85. [PMID: 33179620 DOI: 10.32074/1591-951X-166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Zhao H, Hu H, Chen B, Xu W, Zhao J, Huang C, Xing Y, Lv H, Nie C, Wang J, He Y, Wang SQ, Chen XB. Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications. Front Mol Biosci 2021;8:689139. [PMID: 34422902 DOI: 10.3389/fmolb.2021.689139] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Grant CN, Rhee D, Tracy ET, Aldrink JH, Baertschiger RM, Lautz TB, Glick RD, Rodeberg DA, Ehrlich PF, Christison-Lagay E. Pediatric solid tumors and associated cancer predisposition syndromes: Workup, management, and surveillance. A summary from the APSA cancer committee. J Pediatr Surg 2021:S0022-3468(21)00568-6. [PMID: 34503817 DOI: 10.1016/j.jpedsurg.2021.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Iwashita Y, Ohnishi I, Matsushita Y, Ohtsuka S, Yamashita T, Inaba K, Fukazawa A, Ochiai H, Matsumoto K, Kurono N, Matsushima Y, Mori H, Suzuki S, Suzuki S, Tanioka F, Sugimura H. Geospatial Assessments of DNA Adducts in the Human Stomach: A Model of Field Cancerization. Cancers (Basel) 2021;13:3728. [PMID: 34359626 DOI: 10.3390/cancers13153728] [Reference Citation Analysis]
57 Katoh H, Ishikawa S. Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations. J Hum Genet 2021;66:887-99. [PMID: 34267306 DOI: 10.1038/s10038-021-00960-8] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
58 Zheng G, Sundquist K, Sundquist J, Chen T, Försti A, Hemminki A, Hemminki K. Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer. Clin Epidemiol 2021;13:515-25. [PMID: 34239328 DOI: 10.2147/CLEP.S304332] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Förster A, Brand F, Banan R, Hüneburg R, Weber CAM, Ewert W, Kronenberg J, Previti C, Elyan N, Beyer U, Martens H, Hong B, Bräsen JH, Erbersdobler A, Krauss JK, Stangel M, Samii A, Wolf S, Preller M, Aretz S, Wiese B, Hartmann C, Weber RG. Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin. Acta Neuropathol 2021;142:191-210. [PMID: 33929593 DOI: 10.1007/s00401-021-02307-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, Zhang J, Sun LY, Lin RB, Qiu H, Wang C, Qiu MZ, Cai MY, Wu Q, Liu H, Guan WL, Zhou AP, Zhang YJ, Liu TS, Bi F, Yuan XL, Rao SX, Xin Y, Sheng WQ, Xu HM, Li GX, Ji JF, Zhou ZW, Liang H, Zhang YQ, Jin J, Shen L, Li J, Xu RH. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond) 2021;41:747-95. [PMID: 34197702 DOI: 10.1002/cac2.12193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 50] [Article Influence: 2.0] [Reference Citation Analysis]
61 Pocurull A, Herrera-Pariente C, Carballal S, Llach J, Sánchez A, Carot L, Botargues JM, Cuatrecasas M, Ocaña T, Balaguer F, Bujanda L, Moreira L. Clinical, Molecular and Genetic Characteristics of Early Onset Gastric Cancer: Analysis of a Large Multicenter Study. Cancers (Basel) 2021;13:3132. [PMID: 34201547 DOI: 10.3390/cancers13133132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Battista S, Ambrosio MR, Limarzi F, Gallo G, Saragoni L. Molecular Alterations in Gastric Preneoplastic Lesions and Early Gastric Cancer. Int J Mol Sci 2021;22:6652. [PMID: 34206291 DOI: 10.3390/ijms22136652] [Reference Citation Analysis]
63 Rustgi SD, Ching CK, Kastrinos F. Inherited Predisposition to Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:467-87. [PMID: 34053634 DOI: 10.1016/j.giec.2021.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
64 Wu X, Li D, Chen H, Han J, Zhou H, He Z, Ma Y, Dong B, Wu Y, Matkowskyj KA, Ejaz A, Almhanna K, Wang Q. Evaluation of the reporting quality of guidelines for gastric cancer using the RIGHT checklist. Ann Transl Med 2021;9:1003. [PMID: 34277803 DOI: 10.21037/atm-21-2491] [Reference Citation Analysis]
65 Benesch MGK, Bursey SR, O'Connell AC, Ryan MG, Howard CL, Stockley CC, Mathieson A. CDH1 Gene Mutation Hereditary Diffuse Gastric Cancer Outcomes: Analysis of a Large Cohort, Systematic Review of Endoscopic Surveillance, and Secondary Cancer Risk Postulation. Cancers (Basel) 2021;13:2622. [PMID: 34073553 DOI: 10.3390/cancers13112622] [Reference Citation Analysis]
66 Massari G, Magnoni F, Favia G, Peradze N, Veronesi P, La Vecchia C, Corso G. Frequency of CDH1 Germline Mutations in Non-Gastric Cancers. Cancers (Basel) 2021;13:2321. [PMID: 34066044 DOI: 10.3390/cancers13102321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Tedaldi G, Molinari C, São José C, Barbosa-Matos R, André A, Danesi R, Arcangeli V, Ravegnani M, Saragoni L, Morgagni P, Rebuzzi F, Canale M, Pignatta S, Ferracci E, Martinelli G, Ranzani GN, Oliveira C, Calistri D, Ulivi P. Genetic and Epigenetic Alterations of CDH1 Regulatory Regions in Hereditary and Sporadic Gastric Cancer. Pharmaceuticals (Basel) 2021;14:457. [PMID: 34066170 DOI: 10.3390/ph14050457] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Mukhtar RA, Chien AJ. Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions. Curr Breast Cancer Rep 2021;13:164-70. [DOI: 10.1007/s12609-021-00412-4] [Reference Citation Analysis]
69 Vidal AF, Ferraz RS, El-Husny A, Silva CS, Vinasco-Sandoval T, Magalhães L, Raiol-Moraes M, Barra WF, Pereira CLBL, de Assumpção PP, de Brito LM, Vialle RA, Santos S, Ribeiro-Dos-Santos Â, Ribeiro-Dos-Santos AM. Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation. BMC Cancer 2021;21:363. [PMID: 33827469 DOI: 10.1186/s12885-021-08089-9] [Reference Citation Analysis]
70 Schueler SA, Gamble LA, Curtin BF, Ruff SM, Connolly M, Hannah C, Quezado M, Miettinen M, George M, Blakely AM, Hernandez JM, Heller T, Koh C, Davis JL. Evaluation of confocal laser endomicroscopy for detection of occult gastric carcinoma in CDH1 variant carriers. J Gastrointest Oncol 2021;12:216-25. [PMID: 34012620 DOI: 10.21037/jgo-20-430] [Reference Citation Analysis]
71 Ghidini M, Petrillo A, Botticelli A, Trapani D, Parisi A, La Salvia A, Sajjadi E, Piciotti R, Fusco N, Khakoo S. How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches. J Clin Med 2021;10:1412. [PMID: 33915839 DOI: 10.3390/jcm10071412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Lerner BA, Llor X. Genetic Gastric Cancer Risk Syndromes. Curr Treat Options Gastroenterol 2020;18:604-15. [PMID: 33776403 DOI: 10.1007/s11938-020-00312-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
73 Corso G, Corso F, Bellerba F, Carneiro P, Seixas S, Cioffi A, La Vecchia C, Magnoni F, Bonanni B, Veronesi P, Gandini S, Figueiredo J. Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review. Cancers (Basel) 2021;13:1269. [PMID: 33809393 DOI: 10.3390/cancers13061269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
74 Liu Y, Calzone K, Fasaye GA, Quillin J. CDH1 variants leading to gastric cancer risk management decision-making experiences in emerging adults: 'I am not ready yet'. J Genet Couns 2021;30:1091-104. [PMID: 33655597 DOI: 10.1002/jgc4.1393] [Reference Citation Analysis]
75 Marwitz T, Hüneburg R, Spier I, Lau JF, Kristiansen G, Lingohr P, Kalff JC, Aretz S, Nattermann J, Strassburg CP. Hereditary Diffuse Gastric Cancer: A Comparative Cohort Study According to Pathogenic Variant Status. Cancers (Basel) 2020;12:E3726. [PMID: 33322525 DOI: 10.3390/cancers12123726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
76 El Rami FE, Barsoumian HB, Khneizer GW. Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshell. Ther Adv Med Oncol 2020;12:1758835920967238. [PMID: 33193828 DOI: 10.1177/1758835920967238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Corso G, Bonanni B. E-Cadherin (CDH1 Gene) Germline Mutations in Gastric Cancer: Evolutions and Innovations. Cancers (Basel) 2020;12:E2920. [PMID: 33050628 DOI: 10.3390/cancers12102920] [Reference Citation Analysis]
78 Landeros N, Santoro PM, Carrasco-Avino G, Corvalan AH. Competing Endogenous RNA Networks in the Epithelial to Mesenchymal Transition in Diffuse-Type of Gastric Cancer. Cancers (Basel) 2020;12:E2741. [PMID: 32987716 DOI: 10.3390/cancers12102741] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]